NDATOPICALOINTMENT
Approved
Jan 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TOPICORT (desoximetasone) by PharmaIN is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 1985.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICORT (desoximetasone) is a potent topical corticosteroid ointment approved in 1985 for plaque psoriasis in patients 18 years and older. It works as a corticosteroid hormone receptor agonist, binding to glucocorticoid receptors to reduce inflammation and immune function in affected skin.
LOE Approaching
Product approaching loss of exclusivity with modest competitive pressure (30/100); expect declining team resources and shift toward generic optimization or line extension strategies.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications (4)
Worked on TOPICORT at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.